Skip to main content


What's new

India is a developing country where diabetes is highly prevalent. Leading endocrinologists shared how they utilize the messaging service WhatsApp and Professional CGMs to overcome barriers. Continue Reading »

At the ATTD 2022 conference, diabetes advocates delivered presentations on open-source AID, access to insulin and diabetes supplies, and diabetes stigma in the #dedocº Symposium. Continue Reading »

diaTribe spoke with Dr. Nick Cuttriss, founding director of the ECHO Diabetes Action Network (EDAN), to learn how Project ECHO Diabetes and EDAN use telementoring to address health system failures for people with diabetes in vulnerable communities. Continue Reading »

Civica, a nonprofit pharmaceutical company, announced plans to make generic insulin available for $30 per vial or $55 for five prefilled pens, regardless of insurance status. Continue Reading »

US pharmaceutical companies and insulin manufacturers react to proposed legislation that would cap insulin costs and prevent significant rises in the costs of prescription drugs. Continue Reading »

dStigmatize logo ending diabetes stigma

diaTribe is launching a new website,, to provide a comprehensive resource for understanding, reducing, and ending diabetes stigma. Reducing diabetes stigma starts with education and advocacy. Continue Reading »

As we approach the new year, we want to remind you that if you've met your annual health insurance deductible or are close to meeting it, do not forget to order any diabetes supplies you need before your deductible resets on January 1 (in the US). Continue Reading »

For National Diabetes Awareness and Prevention Month, we asked members of the diaTribe community what access to care means to them. You can check out all of their responses here. Continue Reading »